Cambridge Investment Research Advisors, Inc. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001419186
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q3 2024 · 3404 positions · Total reported value $29.40B · Top-10 concentration 21.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 51.9% · 231 new · 1731 cut · 255 exited
Active Share (vs S&P 500): 71.2% · vs QQQ: 82.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): -0.7% · vs SPY -2.8% · Prev Value $44.58B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): -0.5% · vs SPY -2.6% · Latest Value $45.09B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q3 2024 13F filing, Cambridge Investment Research Advisors, Inc. disclosed 3404 equity positions with a combined reported value of $29.40B. The filing implies a diversified portfolio: its ten largest positions account for 21.0% of reported value. HoldingsHub classifies the profile as Large / Diversified / High Turnover.
The largest disclosed positions as of Q3 2024 were AAPL ($1.05B), VOO ($975.00M), NVDA ($685.11M). By sector, the heaviest allocations are Technology 13.2%, Consumer Discretionary 6.3%. Versus the prior quarter, allocation shifted toward Other (+0.5pp) and away from Technology (-0.6pp).
Versus the prior quarter, Cambridge Investment Research Advisors, Inc. opened 231 new positions, trimmed 1731 and fully exited 255, a turnover rate of 51.9% of positions. The portfolio's overlap with the prior quarter was 89% of names.
The largest new positions opened in Q3 2024 were UTES ($13.15M), RSST ($12.62M), ZSEP ($10.20M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q3 2024)
- UTES ETFIS SER TR I · $13.15M
- RSST TIDAL TR II · $12.62M
- ZSEP INNOVATOR ETFS TRUST · $10.20M
- AHR AMERICAN HEALTHCARE REIT INC · $7.58M
- ZAUG INNOVATOR ETFS TRUST · $6.75M
- BSCW INVESCO EXCH TRD SLF IDX FD · $5.03M
- CPSJ CALAMOS ETF TR · $4.16M
- BBRE J P MORGAN EXCHANGE TRADED F · $4.00M
Fully Exited (vs previous quarter)
No tracked position was fully exited this quarter.
Insider Transactions (Form 4)
Latest Cambridge Investment Research Advisors, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Cambridge Investment Research Advisors, Inc. is an SEC-registered 13F filer based in Fairfield, IA, United States. As of Q2 2026 it reported 4,040 US equity positions with a combined value of $44.58B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: FAIRFIELD, IA, United States
- SEC registration: 801-63930 (status: Approved), registered 2005-02-03
- Regulatory AUM (Form ADV): $130.83B as of 2026-09-11
- Client mix (by RAUM): individual investors 99%, pension and profit-sharing plans 1%
- Website: cambridgestronger.com
Portfolio Structure
- 4,040 positions · $44.58B reported value (Q2 2026)
- Top 10 holdings = 19.1% of reported value
- Largest position: VOO (VANGUARD INDEX FDS) at 3.2%
- Average position size: $11.03M
Sector Tilt
- Information Technology 14.9%
- Consumer Discretionary 4.7%
- Financials 4.6%
- (classified holdings cover 35% of value)
Quarterly Activity
- Q2 2026: 303 new, 1918 added, 1511 reduced, 183 exited
- 308 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
4.51M | $1.05B | 3.58% | Add | |
| 2 |
|
1.85M | $975.00M | 3.32% | Add | |
| 3 |
|
5.64M | $685.11M | 2.33% | Reduce | |
| 4 |
|
1.28M | $623.79M | 2.12% | Hold | |
| 5 |
|
1.05M | $602.94M | 2.05% | Add | |
| 6 |
|
1.89M | $535.70M | 1.82% | Add | |
| 7 |
|
1.20M | $517.71M | 1.76% | Add | |
| 8 |
|
2.35M | $438.76M | 1.49% | Add | |
| 9 |
|
6.28M | $406.72M | 1.38% | Reduce | |
| 10 |
|
582.35K | $334.13M | 1.14% | Hold | |
| 11 |
|
678.48K | $312.28M | 1.06% | Add | |
| 12 |
|
4.50M | $260.23M | 0.89% | Add | |
| 13 |
|
3.02M | $227.21M | 0.77% | Add | |
| 14 |
|
2.24M | $189.05M | 0.64% | Add | |
| 15 |
|
1.02M | $177.96M | 0.60% | Add | |
| 16 |
|
889.93K | $176.26M | 0.60% | Add | |
| 17 |
|
451.98K | $173.53M | 0.59% | Hold | |
| 18 |
|
977.68K | $162.15M | 0.55% | Reduce | |
| 19 |
|
281.94K | $161.40M | 0.55% | Reduce | |
| 20 |
|
901.76K | $150.77M | 0.51% | Add | |
| 21 |
|
164.83K | $146.03M | 0.50% | Reduce | |
| 22 |
|
3.79M | $138.01M | 0.47% | Add | |
| 23 |
|
1.17M | $136.67M | 0.47% | Add | |
| 24 |
|
597.50K | $134.89M | 0.46% | Add | |
| 25 |
|
549.57K | $133.58M | 0.45% | Add | |
| 26 |
|
1.46M | $133.50M | 0.45% | Reduce | |
| 27 |
|
2.52M | $132.95M | 0.45% | Reduce | |
| 28 |
|
505.06K | $132.14M | 0.45% | Reduce | |
| 29 |
|
1.29M | $131.10M | 0.45% | Add | |
| 30 |
|
602.38K | $127.02M | 0.43% | Add | |
| 31 |
|
2.52M | $126.55M | 0.43% | Reduce | |
| 32 |
|
2.09M | $123.65M | 0.42% | Add | |
| 33 |
|
657.54K | $117.81M | 0.40% | Add | |
| 34 |
|
1.95M | $115.87M | 0.39% | Add | |
| 35 |
|
663.97K | $114.53M | 0.39% | Add | |
| 36 |
|
1.24M | $113.76M | 0.39% | Add | |
| 37 |
|
1.64M | $110.67M | 0.38% | Reduce | |
| 38 |
|
631.51K | $109.38M | 0.37% | Add | |
| 39 |
|
123.26K | $109.27M | 0.37% | Add | |
| 40 |
|
608.04K | $109.02M | 0.37% | Add | |
| 41 |
|
1.32M | $103.51M | 0.35% | Reduce | |
| 42 |
|
567.46K | $103.27M | 0.35% | Add | |
| 43 |
|
804.16K | $103.09M | 0.35% | Add | |
| 44 |
|
374.45K | $102.95M | 0.35% | Reduce | |
| 45 |
|
1.01M | $101.21M | 0.34% | Reduce | |
| 46 |
|
456.35K | $100.42M | 0.34% | Add | |
| 47 |
|
495.07K | $97.77M | 0.33% | Add | |
| 48 |
|
995.65K | $95.33M | 0.32% | Add | |
| 49 |
|
1.05M | $95.30M | 0.32% | Reduce | |
| 50 |
|
1.18M | $95.17M | 0.32% | Add | |
FAQ
What did Cambridge Investment Research Advisors, Inc. buy in 2024-Q3?
In its 2024-Q3 13F filing, Cambridge Investment Research Advisors, Inc. reported 3404 equity positions worth $29.40B in aggregate; its largest disclosed positions were AAPL ($1.05B), VOO ($975.00M), NVDA ($685.11M).
How large is Cambridge Investment Research Advisors, Inc.'s portfolio?
Cambridge Investment Research Advisors, Inc. reported $29.40B of long equity holdings across 3404 positions as of 2024-Q3. Top-10 holdings account for 21.0% of reported value.
What is Cambridge Investment Research Advisors, Inc.'s investment style?
HoldingsHub classifies the portfolio as Large / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.